European Parliament (EP) and Council negotiators reached on Thursday a provisional deal for an EU digital Covid certificate to facilitate free movement in Europe during the pandemic, EP informed.
The certificate will be available in either digital or paper format. It will attest that a person has been vaccinated against coronavirus or has a recent negative test result or has recovered from the infection. In practice, these will be three distinct certificates. A common EU framework will allow member states to issue certificates that will then be accepted in other EU countries.
The EU digital Covid Certificate regulation should be in place for 12 months. The certificate will not be a precondition to exercise the right to free movement and will not be considered a travel document.
To make “affordable and accessible testing” more widely available, the European Commission committed to mobilize “at least €100 million” under the Emergency Support Instrument for the purchase of tests for SARS-CoV-2 infection for the purpose of issuing EU digital Covid test certificates. This should particularly benefit persons who cross borders daily or frequently to go to work or school, visit close relatives, seek medical care, or to take care of loved ones.
Negotiators agreed that, if necessary, additional funding above €100 million should be mobilized, subject to approval by the budgetary authorities.
Member states should not impose additional travel restrictions in response to the COVID-19 pandemic, such as quarantine, self-isolation or testing, “unless they are necessary and proportionate to safeguard public health”. Available scientific evidence, “including epidemiological data published by the European Centre for Disease Prevention and Control (ECDC)” should be taken into account. Such measures should be notified to other member states and the Commission at the latest 48 hours in advance.
Member states must accept vaccination certificates issued in other member states for persons inoculated with a vaccine authorized for use in the EU by the European Medicines Agency (EMA) (currently Pfizer-BioNTech, Moderna, AstraZeneca and Janssen). It will be up to the member states to decide whether they also accept vaccination certificates that have been authorized by other Member States following national authorization procedures or for vaccines listed by the World Health Organization (WHO) for emergency use.
The certificates will be verified to prevent fraud and forgery, as will be the authenticity of the electronic seals included in the document. Personal data obtained from the certificates cannot be stored in destination member states and there will be no central database established at EU level. The list of entities that will process and receive data will be public so that citizens can exercise their data protection rights under the General Data Protection Regulation.
The agreed text will now be put to the Civil Liberties Committee on 26 May and then to plenary for approval as well as to the Council. If confirmed by the committee, it will be tabled for adoption in plenary during the June I plenary session (7-10 June 2021).
